Print this page Email this page
Users Online: 444
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Contacts Login 

 Table of Contents  
Year : 2018  |  Volume : 32  |  Issue : 1  |  Page : 76-77

World health organization releases global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics

Department of Community Medicine, Shri Sathya Sai Medical College and Research Institute, Chennai, Tamil Nadu, India

Date of Web Publication18-Jun-2018

Correspondence Address:
Dr. Saurabh RamBihariLal Shrivastava
3rd Floor, Department of Community Medicine, Shri Sathya Sai Medical College and Research Institute, Ammapettai Village, Thiruporur - Guduvancherry Main Road, Sembakkam Post, Kanchipuram - 603 108, Tamil Nadu
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/jms.jms_25_17

Rights and Permissions

How to cite this article:
Shrivastava SR, Shrivastava PS, Ramasamy J. World health organization releases global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. J Med Soc 2018;32:76-7

How to cite this URL:
Shrivastava SR, Shrivastava PS, Ramasamy J. World health organization releases global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. J Med Soc [serial online] 2018 [cited 2021 Feb 28];32:76-7. Available from:


Antibiotic resistance has been recognized as one of the major fears to the global health and allied sectors, as it can affect anybody regardless of their age or geographical location.[1] Even though it is a natural phenomenon, misuse of antibiotics in humans and animals has significantly expedited the process.[1] In fact, antibiotic resistance has led to adverse consequences such as prolonged hospitalization, increased medical expenses, overburdened public health system, and even increased mortality rates.[1],[2]

As the problem of antibiotic resistance is evergrowing, and if no active interventions are taken, very soon, we will be out of treatment options to control the infections.[2] Keeping the magnitude of the problem in mind and realizing the bitter fact that if everything is left to market dynamics, novel antibiotics, which we promptly require, cannot be developed in time, the World Health Organization (WHO) has released a list of antibiotic-resistant priority pathogens.[2] This list consists of 12 groups of bacteria, which are ranked under three categories, namely, critical, high, and medium priority.[2]

The critical group consists of bacteria which pose threat in health-care establishments where patients require venous/arterial catheter or a ventilator for providing adequate care, and thus make them extremely susceptible to bloodstream infections or life-threatening pneumonia.[2],[3] Furthermore, bacteria categorized under the high and medium priorities are some of the other infectious agents responsible for causing common infections.[3] The standards for the selection of pathogens were on the basis of the urgency of the need of the antibiotics, the extent of the threat posed to human health (depending on the fatal nature of infections, duration of hospitalization for treatment, rates of acquiring resistance to the existing antibiotics, and speed of transmission between animals or from animals to humans or from person to person), the preventable nature of the infection, availability of treatment options, and whether new antibiotics to treat the infections are already in the research and development (R and D) pipeline.[2],[3]

Moreover, the list is actually a new tool to motivate policymakers to invest in the basic science and R and D activities for the discovery of new antibiotics.[2],[3] Further, it is extremely important to realize that, though R and D activities are vital, it cannot solve the crisis on its own.[1],[4] The need of the hour is to promote the rational use of antibiotics in humans and animals, and steps should be taken at all levels to minimize the impact and spread of resistance.[1],[4]

To conclude, effective antibiotics are needed for health systems, and so collaborative actions are required in today's date for a better tomorrow. The list developed by the WHO is a marker to promote R and D activities, to respond or be better prepared to deal with the global public health concern of antibiotic resistance.

Financial support and sponsorship


Conflicts of interest

There are no conflicts of interest.

  References Top

World Health Organization. Antibiotic Resistance – Fact Sheet; 2016. Available from: [Last accessed on 2017 Mar 08].  Back to cited text no. 1
World Health Organization. WHO Publishes List of Bacteria for Which New Antibiotics are Urgently Needed; 2017. Available from: [Last accessed on 2017 Mar 08].  Back to cited text no. 2
World Health Organization. Global Priority List of Antibiotic-Resistant Bacteria to Guide Research, Discovery, and Development of New Antibiotics. Geneva: WHO Press; 2017. p. 1-7.  Back to cited text no. 3
Shrivastava SR, Shrivastava PS, Ramasamy J. Much more is expected from nations to counter antimicrobial resistance: World Health Organization. J Res Med Sci 2015;20:718-9.  Back to cited text no. 4
[PUBMED]  [Full text]  

This article has been cited by
1 The microbiome of a polluted urban lake harbors pathogens with diverse antimicrobial resistance and virulence genes
Jorge Quillaguamán,Daniel Guzmán,Melina Campero,Claudia Hoepfner,Laura Relos,Daniela Mendieta,Shawn M. Higdon,Daniel Eid,Carla E. Fernández
Environmental Pollution. 2021; : 116488
[Pubmed] | [DOI]
2 Thioether-linked Dihydropyrrol-2-one Analogues as PqsR Antagonists against Antibiotic Resistant Pseudomonas aeruginosa
Shekh Sabir,Dittu Suresh,Sujatha Subramoni,Theerthankar Das,Mohan Bhadbhade,David StC. Black,Scott A. Rice,Naresh Kumar
Bioorganic & Medicinal Chemistry. 2021; : 115967
[Pubmed] | [DOI]
3 From Farm-to-Fork: E. Coli from an Intensive Pig Production System in South Africa Shows High Resistance to Critically Important Antibiotics for Human and Animal Use
Shima E. Abdalla,Akebe Luther King Abia,Daniel G. Amoako,Keith Perrett,Linda A. Bester,Sabiha Y. Essack
Antibiotics. 2021; 10(2): 178
[Pubmed] | [DOI]
4 Bloodstream Infections Caused by Carbapenem-Resistant Enterobacterales: Risk Factors for Mortality, Antimicrobial Therapy and Treatment Outcomes from a Prospective Multicenter Study
Chaoe Zhou,Longyang Jin,Qi Wang,Xiaojuan Wang,Fengning Chen,Yue Gao,Chunjiang Zhao,Hongbin Chen,Bin Cao,Hui Wang
Infection and Drug Resistance. 2021; Volume 14: 731
[Pubmed] | [DOI]
5 High-yield production of active recombinant S. simulans lysostaphin expressed in E. coli in a laboratory bioreactor
Zeynep Efsun Duman-Özdamar,Aise Ünlü,Hayriye Ünal,John M. Woodley,Baris Bi?nay
Protein Expression and Purification. 2021; 177: 105753
[Pubmed] | [DOI]
6 Evaluation of a Phenotypic Algorithm to Direct Carbapenemase Testing in Pseudomonas aeruginosa: Validation in a Multicenter German Cohort
Christian M. Gill,Michael Kresken,Harald Seifert,David P. Nicolau
Microbial Drug Resistance. 2021;
[Pubmed] | [DOI]
7 Overcoming Challenges to Make Bacteriophage Therapy Standard Clinical Treatment Practice for Cystic Fibrosis
Renee N. Ng,Anna S. Tai,Barbara J. Chang,Stephen M. Stick,Anthony Kicic
Frontiers in Microbiology. 2021; 11
[Pubmed] | [DOI]
8 The Polyaminoisoprenyl Potentiator NV716 Revives Old Disused Antibiotics against Intracellular Forms of Infection by Pseudomonas aeruginosa
Gang Wang,Jean-Michel Brunel,Jean-Michel Bolla,Françoise Van Bambeke
Antimicrobial Agents and Chemotherapy. 2020; 65(3)
[Pubmed] | [DOI]
9 The Application of Porphyrins and Their Analogues for Inactivation of Viruses
Natalya Sh. Lebedeva,Yury A. Gubarev,Mikhail O. Koifman,Oskar I. Koifman
Molecules. 2020; 25(19): 4368
[Pubmed] | [DOI]
10 Phenotypic Tracking of Antibiotic Resistance Spread via Transformation from Environment to Clinic by Reverse D2O Single-Cell Raman Probing
Hong-Zhe Li,DanDan Zhang,Kai Yang,Xin-Li An,Qiang Pu,Shao-Min Lin,Jian-Qiang Su,Li Cui
Analytical Chemistry. 2020;
[Pubmed] | [DOI]
11 Antibiotics Resistance Pattern of Coliform Bacteria Isolated from Slaughterhouse Wastewater in Jega Town, Kebbi State, Nigeria
Adamu Almustapha Aliero,Namadina Hassan Jega,Ahmad Ibrahim Bagudo,Sahabi Sule Manga,Kabiru Hussaini
Borneo Journal of Pharmacy. 2020; 3(3): 170
[Pubmed] | [DOI]
12 Two Forms of Tyrosyl-tRNA Synthetase from Pseudomonas aeruginosa: Characterization and Discovery of Inhibitory Compounds
Casey A. Hughes,Varesh Gorabi,Yaritza Escamilla,Frank B. Dean,James M. Bullard
SLAS DISCOVERY: Advancing the Science of Drug Discovery. 2020; 25(9): 1072
[Pubmed] | [DOI]

Characterization of Hypervirulent Extended-Spectrum ß-Lactamase-Producing Klebsiella pneumoniae Among Urinary Tract Infections: The First Report from Iran

Azadeh Taraghian,Bahram Nasr Esfahani,Sharareh Moghim,Hossein Fazeli
Infection and Drug Resistance. 2020; Volume 13: 3103
[Pubmed] | [DOI]
14 Facile Synthesis of Antimicrobial Aloe Vera-“Smart” Triiodide-PVP Biomaterials
Zehra Edis,Samir Haj Bloukh
Biomimetics. 2020; 5(3): 45
[Pubmed] | [DOI]
15 Molecular Detection and PCR-RFLP Analysis of Mucoviscosity-Associated Gene A (magA) in Clinical Isolates of Multidrug-Resistant Klebsiella pneumoniae in Bangladesh
Md. Hazrat Ali,Saeed Anwar,Nusrat Jahan Toma,Ikram Rafid,Md. Kamrul Hasan,Md. Javed Foysal
The Open Microbiology Journal. 2020; 14(1): 196
[Pubmed] | [DOI]
16 Rational Drug Design for Pseudomonas aeruginosa PqsA Enzyme: An in silico Guided Study to Block Biofilm Formation
Bilal Shaker,Sajjad Ahmad,Thi Duc Thai,Seong-il Eyun,Dokyun Na
Frontiers in Molecular Biosciences. 2020; 7
[Pubmed] | [DOI]
17 Molecular Epidemiology of Acinetobacter calcoaceticus-Acinetobacter baumannii Complex Isolated From Children at the Hospital Infantil de México Federico Gómez
Jetsi Mancilla-Rojano,Sara A. Ochoa,Juan Pablo Reyes-Grajeda,Víctor Flores,Oscar Medina-Contreras,Karina Espinosa-Mazariego,Israel Parra-Ortega,Daniela De La Rosa-Zamboni,María del Carmen Castellanos-Cruz,José Arellano-Galindo,Miguel A. Cevallos,Rigoberto Hernández-Castro,Juan Xicohtencatl-Cortes,Ariadnna Cruz-Córdova
Frontiers in Microbiology. 2020; 11
[Pubmed] | [DOI]
18 In vitro Synergistic Activity of Antimicrobial Combinations Against blaKPC and blaNDM-Producing Enterobacterales With blaIMP or mcr Genes
Chaoe Zhou,Qi Wang,Longyang Jin,Ruobing Wang,Yuyao Yin,Shijun Sun,Jiangang Zhang,Hui Wang
Frontiers in Microbiology. 2020; 11
[Pubmed] | [DOI]
19 MWCNT-oxazolidinone conjugates with antibacterial activity
Bibiana Moreno-Valle,José A. Alatorre-Barajas,Yadira Gochi-Ponce,Eleazar Alcántar-Zavala,Yazmín Yorely Rivera-Lugo,Julio Montes-Ávila,Balter Trujillo-Navarrete,Gabriel Alonso-Núñez,Edgar A. Reynoso-Soto,Adrián Ochoa-Terán
Journal of Nanoparticle Research. 2020; 22(11)
[Pubmed] | [DOI]
20 Bactericidal Antibacterial Mechanism of Plant Synthesized Silver, Gold and Bimetallic Nanoparticles
Olufunto T. Fanoro,Oluwatobi S. Oluwafemi
Pharmaceutics. 2020; 12(11): 1044
[Pubmed] | [DOI]
21 Structural Modifications of the Quinolin-4-yloxy Core to Obtain New Staphylococcus aureus NorA Inhibitors
Rolando Cannalire,Gianmarco Mangiaterra,Tommaso Felicetti,Andrea Astolfi,Nicholas Cedraro,Serena Massari,Giuseppe Manfroni,Oriana Tabarrini,Salvatore Vaiasicca,Maria Letizia Barreca,Violetta Cecchetti,Francesca Biavasco,Stefano Sabatini
International Journal of Molecular Sciences. 2020; 21(19): 7037
[Pubmed] | [DOI]
22 Pathogenic spectrum of blood stream infections and resistance pattern in Gram-negative bacteria from Aljouf region of Saudi Arabia
Altaf Bandy,Abdulrahman Hamdan Almaeen,Grzegorz Wozniakowski
PLOS ONE. 2020; 15(6): e0233704
[Pubmed] | [DOI]
23 Antibacterial Activity of Colloidal Silver against Gram-Negative and Gram-Positive Bacteria
Andrea Vila Domínguez,Rafael Ayerbe Algaba,Andrea Miró Canturri,Ángel Rodríguez Villodres,Younes Smani
Antibiotics. 2020; 9(1): 36
[Pubmed] | [DOI]
24 Characterization of Salmonella Isolates from Various Geographical Regions of the Caucasus and Their Susceptibility to Bacteriophages
Khatuna Makalatia,Elene Kakabadze,Jeroen Wagemans,Nino Grdzelishvili,Nata Bakuradze,Gulnara Natroshvili,Nino Macharashvili,Anahit Sedrakyan,Karine Arakelova,Zhanna Ktsoyan,Magdalina Zakharyan,Zaruhi Gevorgyan,Armine Mnatsakanyan,Farida Tishkova,Cédric Lood,Dieter Vandenheuvel,Rob Lavigne,Jean-Paul Pirnay,Daniel De Vos,Nina Chanishvili,Maia Merabishvili
Viruses. 2020; 12(12): 1418
[Pubmed] | [DOI]
25 Investigation of In-Vitro Adaptation toward Sodium Bituminosulfonate in Staphylococcus aureus
Marko Blisse,Evgeny A. Idelevich,Karsten Becker
Microorganisms. 2020; 8(12): 1962
[Pubmed] | [DOI]
26 Regulating antimicrobial sales in Saudi Arabia: Achievements and challenges
Tahani Musleh Almeleebia,Abdullah A. Alhifany,Fahdah Almutairi,Mohannad Alshibani,Abdulaziz M. Alhossan
International Journal of Clinical Practice. 2020;
[Pubmed] | [DOI]
27 Extended Spectrum Beta-Lactamase-Resistant Determinants among Carbapenem-Resistant Enterobacteriaceae from Beef Cattle in the North West Province, South Africa: A Critical Assessment of Their Possible Public Health Implications
Lungisile Tshitshi,Madira Coutlyne Manganyi,Peter Kotsoana Montso,Moses Mbewe,Collins Njie Ateba
Antibiotics. 2020; 9(11): 820
[Pubmed] | [DOI]
28 In Vitro and In Vivo Assessment of the Efficacy of Bromoageliferin, an Alkaloid Isolated from the Sponge Agelas dilatata, against Pseudomonas aeruginosa
Dawrin Pech-Puch,Mar Pérez-Povedano,Marta Martinez-Guitian,Cristina Lasarte-Monterrubio,Juan Carlos Vázquez-Ucha,Germán Bou,Jaime Rodríguez,Alejandro Beceiro,Carlos Jimenez
Marine Drugs. 2020; 18(6): 326
[Pubmed] | [DOI]
29 A profile of the GenePOC Carba C assay for the detection and differentiation of gene sequences associated with carbapenem-non-susceptibility
Luis Lucena Baeza,Axel Hamprecht
Expert Review of Molecular Diagnostics. 2020; : 1
[Pubmed] | [DOI]
30 Design, Synthesis and Biological Evaluation of Novel Anthraniloyl-AMP Mimics as PQS Biosynthesis Inhibitors Against Pseudomonas aeruginosa Resistance
Shekh Sabir,Sujatha Subramoni,Theerthankar Das,David StC. Black,Scott A. Rice,Naresh Kumar
Molecules. 2020; 25(13): 3103
[Pubmed] | [DOI]
31 A cost-effective combination of Rose Bengal and off-the-shelf cationic polystyrene for the photodynamic inactivation of Pseudomonas aeruginosa
Carla Arnau del Valle,Vanesa Pérez-Laguna,Ignacio Muñoz Resta,Raquel Gavara,Carles Felip-León,Juan F. Miravet,Antonio Rezusta,Francisco Galindo
Materials Science and Engineering: C. 2020; 117: 111302
[Pubmed] | [DOI]
32 Destroying antimicrobial resistant bacteria (AMR) and difficult, opportunistic pathogen using cavitation and natural oils/plant extract
Maya B. Mane,Vinay M. Bhandari,Kshama Balapure,Vivek V. Ranade
Ultrasonics Sonochemistry. 2020; 69: 105272
[Pubmed] | [DOI]
33 Biosynthesis of NiFe 2 O 4 @Ag Nanocomposite and Assessment of Its Effect on Expression of norA Gene in Staphylococcus aureus
Nozhat Pourmehdi,Zeinab Moradi-Shoeili,Akram Sadat Naeemi,Ali Salehzadeh
Chemistry & Biodiversity. 2020;
[Pubmed] | [DOI]
34 Synthesis of Fmoc-Triazine Amino Acids and Its Application in the Synthesis of Short Antibacterial Peptidomimetics
Pethaiah Gunasekaran,Eun Young Kim,Jian Lee,Eun Kyoung Ryu,Song Yub Shin,Jeong Kyu Bang
International Journal of Molecular Sciences. 2020; 21(10): 3602
[Pubmed] | [DOI]
35 Structure based drug designing and discovery of promising lead molecules against UDP-N-acetylenolpyruvoylglucosamine reductase (MurB): A potential drug target in multi-drug resistant Acinetobacter baumannii
Gizachew Muluneh Amera,Rameez Jabeer Khan,Amita Pathak,Rajat Kumar Jha,Monika Jain,Jayaraman Muthukumaran,Amit Kumar Singh
Journal of Molecular Graphics and Modelling. 2020; 100: 107675
[Pubmed] | [DOI]
36 Prioritization of Mur family drug targets against A. baumannii and identification of their homologous proteins through molecular phylogeny, primary sequence, and structural analysis
Gizachew Muluneh Amera,Rameez Jabeer Khan,Rajat Kumar Jha,Amita Pathak,Jayaraman Muthukumaran,Amit Kumar Singh
Journal of Genetic Engineering and Biotechnology. 2020; 18(1)
[Pubmed] | [DOI]
37 “Smart” Antimicrobial Nanocomplexes with Potential to Decrease Surgical Site Infections (SSI)
Zehra Edis,Samir Haj Bloukh,May Reda Ibrahim,Hamed Abu Sara
Pharmaceutics. 2020; 12(4): 361
[Pubmed] | [DOI]
38 Computer aided ligand based screening for identification of promising molecules against enzymes involved in peptidoglycan biosynthetic pathway from Acinetobacter baumannii
Gizachew Muluneh Amera,Rameez Jabeer Khan,Amita Pathak,Rajat Kumar Jha,Jayaraman Muthukumaran,Amit Kumar Singh
Microbial Pathogenesis. 2020; : 104205
[Pubmed] | [DOI]
39 Recent Drug-Repurposing-Driven Advances in the Discovery of Novel Antibiotics
Ananda Kumar Konreddy,Grandhe Usha Rani,Kyeong Lee,Yongseok Choi
Current Medicinal Chemistry. 2019; 26(28): 5363
[Pubmed] | [DOI]
40 Photoinduced Antibacterial Activity of the Essential Oils from Eugenia brasiliensis Lam and Piper mosenii C. DC. by Blue Led Light
Rakel Olinda Macedo da Silva,José Walber Gonçalves Castro,Orlando de Menezes Dantas Junior,Ana Carolina Justino de Araújo,Maria Karollyna do Nascimento Silva Leandro,Raíra Justino Oliveira Costa,Luciely Leite Pinto,Lívia Maria Garcia Leandro,Luiz E. da Silva,Wanderlei do Amaral,Lucas D. Parabocz,Aurea P. Ferriani,Bruna Garcia,Beatriz H. L. N. Sales Maia,Janaína Esmeraldo Rocha,Camila Fonseca Bezerra,Thiago Sampaio de Freitas,Maria Socorro Costa,Fábia Ferreira Campina,Edinardo Fagner Ferreira Matias,Marcello Iriti,Henrique Douglas Melo Coutinho
Antibiotics. 2019; 8(4): 242
[Pubmed] | [DOI]
41 Studies on Antibacterial Activity and Diversity of Cultivable Actinobacteria Isolated from Mangrove Soil in Futian and Maoweihai of China
Feina Li,Shaowei Liu,Qinpei Lu,Hongyun Zheng,Ilya A. Osterman,Dmitry A. Lukyanov,Petr V. Sergiev,Olga A. Dontsova,Shuangshuang Liu,Jingjing Ye,Dalin Huang,Chenghang Sun
Evidence-Based Complementary and Alternative Medicine. 2019; 2019: 1
[Pubmed] | [DOI]
42 Efficacy of colistin alone and in various combinations for the treatment of experimental osteomyelitis due to carbapenemase-producing Klebsiella pneumoniae
Anne-Claude Crémieux,Aurélien Dinh,Patrice Nordmann,William Mouton,Pierre Tattevin,Idir Ghout,Aurelie Jayol,Omar Aimer,Laure Gatin,Marie-Clémence Verdier,Azzam Saleh-Mghir,Frédéric Laurent
Journal of Antimicrobial Chemotherapy. 2019;
[Pubmed] | [DOI]
43 Screening of promising molecules against MurG as drug target in multi-drug-resistant-Acinetobacter baumannii - insights from comparative protein modeling, molecular docking and molecular dynamics simulation
Gizachew Muluneh Amera,Rameez Jabeer Khan,Amita Pathak,Rajat Kumar Jha,Jayaraman Muthukumaran,Amit Kumar Singh
Journal of Biomolecular Structure and Dynamics. 2019; : 1
[Pubmed] | [DOI]
44 Classification of Staphylococcus Aureus FabI Inhibitors by Machine Learning Techniques
Vinicius Gonçalves Maltarollo
International Journal of Quantitative Structure-Property Relationships. 2019; 4(4): 1
[Pubmed] | [DOI]
45 Amphiphilic Triazine Polymer Derivatives as Antibacterial And Anti-atopic Agents in Mice Model
Pethaiah Gunasekaran,meiqi Fan,Eun Young Kim,Jun Ho Shin,Ji Eun Lee,Eun Ju Son,Jaehi Kim,Eunha Hwang,Min Su Yim,Eun-Hee Kim,Young-Jin Choi,Young-Ho Lee,Young-Ho Chung,Hak Nam Kim,Eun Kyoung Ryu,Song Yub Shin,Eun-Kyung Kim,Jeong Kyu Bang
Scientific Reports. 2019; 9(1)
[Pubmed] | [DOI]
46 Mutant selection window of clarithromycin for clinical isolates of Helicobacter pylori
Zi-Han Feng,Ling Fan,Jing Yang,Xing-Yue Huo,Yan Guo,Yi Zhang,Chun-Hui Lan
BMC Microbiology. 2019; 19(1)
[Pubmed] | [DOI]
47 Bacteriophage trigger antiviral immunity and prevent clearance of bacterial infection
Johanna M. Sweere,Jonas D. Van Belleghem,Heather Ishak,Michelle S. Bach,Medeea Popescu,Vivekananda Sunkari,Gernot Kaber,Robert Manasherob,Gina A. Suh,Xiou Cao,Christiaan R. de Vries,Dung N. Lam,Payton L. Marshall,Maria Birukova,Ethan Katznelson,Daniel V. Lazzareschi,Swathi Balaji,Sundeep G. Keswani,Thomas R. Hawn,Patrick R. Secor,Paul L. Bollyky
Science. 2019; 363(6434): eaat9691
[Pubmed] | [DOI]
48 Broad Bactericidal Activity of the Myoviridae Bacteriophage Lysins LysAm24, LysECD7, and LysSi3 against Gram-Negative ESKAPE Pathogens
Nataliia Antonova,Daria Vasina,Anastasiya Lendel,Evgeny Usachev,Valentine Makarov,Alexander Gintsburg,Artem Tkachuk,Vladimir Gushchin
Viruses. 2019; 11(3): 284
[Pubmed] | [DOI]
49 Non-Lytic Antibacterial Peptides That Translocate Through Bacterial Membranes to Act on Intracellular Targets
Marlon H. Cardoso,Beatriz T. Meneguetti,Bruna O. Costa,Danieli F. Buccini,Karen G. N. Oshiro,Sergio L. E. Preza,Cristiano M. E. Carvalho,Ludovico Migliolo,Octávio L. Franco
International Journal of Molecular Sciences. 2019; 20(19): 4877
[Pubmed] | [DOI]
50 World Health Organization Report: Current Crisis of Antibiotic Resistance
Amin Talebi Bezmin Abadi,Albert A. Rizvanov,Thomas Haertlé,Nataliya L. Blatt
BioNanoScience. 2019;
[Pubmed] | [DOI]
51 Public Awareness about Antibiotic Use and Resistance among Residents in Highland Areas of Vietnam
Thuy Van Ha,An Mai Thi Nguyen,Ha Song Thi Nguyen
BioMed Research International. 2019; 2019: 1
[Pubmed] | [DOI]
52 Anti-Helicobacter pylori and Anti-inflammatory Properties of Eugenia uniflora L.
Jessica Raquel Borges Monteiro,Juliana Santa Ardisson,Brena Ramos Athaydes,Rita de Cássia Ribeiro Gonçalves,Ricardo Pereira Rodrigues,Ricardo Machado Kuster,Rodrigo Rezende Kitagawa
Brazilian Archives of Biology and Technology. 2019; 62
[Pubmed] | [DOI]
53 Photoinactivation of microorganisms with sub-micromolar concentrations of imidazolium metallophthalocyanine salts
Rafael T. Aroso,Mário J.F. Calvete,Barbara Pucelik,Grzegorz Dubin,Luis G. Arnaut,Mariette M. Pereira,Janusz M. Dabrowski
European Journal of Medicinal Chemistry. 2019; : 111740
[Pubmed] | [DOI]
54 Dynamics of Drug Resistance: Optimal Control of an Infectious Disease
Naveed Chehrazi,Lauren E Cipriano,Eva E. Enns
SSRN Electronic Journal. 2017;
[Pubmed] | [DOI]


Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

  In this article

 Article Access Statistics
    PDF Downloaded1234    
    Comments [Add]    
    Cited by others 54    

Recommend this journal